1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
F Alongi, M Rigo, V Figlia, F Cuccia, N Giaj-Levra… - Radiation …, 2020 - Springer
Abstract Background Unity Elekta is a unique magnetic resonance (MR)-linac that
conjugates a 1.5 Tesla MR unit with a 7 MV flattening filter free accelerator. A prospective …
conjugates a 1.5 Tesla MR unit with a 7 MV flattening filter free accelerator. A prospective …
[PDF][PDF] Artificial intelligence and statistical models for the prediction of radiotherapy toxicity in prostate cancer: A systematic review
Background: Prostate cancer (PCa) is the second most common cancer in men, and
radiotherapy (RT) is one of the main treatment options. Although effective, RT can cause …
radiotherapy (RT) is one of the main treatment options. Although effective, RT can cause …
Rectal spacer hydrogel in 1.5 T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes
F Alongi, M Rigo, V Figlia, F Cuccia… - The British Journal of …, 2021 - academic.oup.com
Objective: The main aim of the current analysis was to explore the hypothetical advantages
using rectal spacer during 1.5 T MR-guided and daily adapted prostate cancer stereotactic …
using rectal spacer during 1.5 T MR-guided and daily adapted prostate cancer stereotactic …
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial
Simple summary Stereotactic body radiotherapy (SBRT) of 35–36.25 Gy in five fractions with
the CyberKnife System yields excellent control with low toxicity in low–intermediate-risk …
the CyberKnife System yields excellent control with low toxicity in low–intermediate-risk …
In curative stereotactic body radiation therapy for prostate cancer, there is a high possibility that 45 Gy in five fractions will not Be tolerated without a hydrogel spacer
S Sawayanagi, H Yamashita, M Ogita, T Kawai, Y Sato… - Cancers, 2024 - mdpi.com
Simple Summary While stereotactic body radiation therapy (SBRT) has become increasingly
used for the treatment of non-metastatic prostate cancer since its insurance coverage in …
used for the treatment of non-metastatic prostate cancer since its insurance coverage in …
Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience
F Cuccia, M Tamburo, A Piras, G Mortellaro, A Iudica… - Medicina, 2023 - mdpi.com
Background: The favorable role of SBRT for lymph-nodal oligometastases from prostate
cancer has been reported by several retrospective and prospective experiences, suggesting …
cancer has been reported by several retrospective and prospective experiences, suggesting …
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective …
L Yao, J Shou, S Wang, Y Song, H Fang, N Lu… - Radiation …, 2020 - Springer
Background There is an increasing application of moderately hypofractionated radiotherapy
for prostate cancer. We presented our outcomes and treatment-related toxicities with …
for prostate cancer. We presented our outcomes and treatment-related toxicities with …
Quantifying the impact of SpaceOAR hydrogel on inter‐fractional rectal and bladder dose during 0.35 T MR‐guided prostate adaptive radiotherapy
R Farjam, SS Mahase, SL Chen… - Journal of applied …, 2021 - Wiley Online Library
Purpose To investigate the impact of rectal spacing on inter‐fractional rectal and bladder
dose and the need for adaptive planning in prostate cancer patients undergoing SBRT with …
dose and the need for adaptive planning in prostate cancer patients undergoing SBRT with …
Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer
Y Takakusagi, T Oike, K Kano, W Anno, K Tsuchida… - Plos one, 2020 - journals.plos.org
Background This study aimed to explain the dynamics of prostate-specific antigen (PSA)
levels in patients with prostate cancer who were treated with carbon ion radiotherapy (CIRT) …
levels in patients with prostate cancer who were treated with carbon ion radiotherapy (CIRT) …
Helical tomotherapy for prostate cancer radiation therapy: An audit of early toxicity and quality of life
B Kunheri, JS Lakshmi, GC Ravindran… - Journal of Cancer …, 2021 - journals.lww.com
Background: Radiation plays a major role in the management of localized prostate cancer
(CaP). There are limited studies reporting the quality of life (QOL) and toxicity with CaP …
(CaP). There are limited studies reporting the quality of life (QOL) and toxicity with CaP …